BlackRock’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
564,803
+475,822
| +535% | +$1.14M | ﹤0.01% | 4092 |
|
|
2025
Q1 | $383K | Sell |
88,981
-5,036
| -5% | -$21.7K | ﹤0.01% | 4416 |
|
|
2024
Q4 | $809K | Buy |
94,017
+71,884
| +325% | +$618K | ﹤0.01% | 4221 |
|
|
2024
Q3 | $376K | Sell |
22,133
-7,232
| -25% | -$123K | ﹤0.01% | 4344 |
|
|
2024
Q2 | $443K | Sell |
29,365
-70,001
| -70% | -$1.06M | ﹤0.01% | 4322 |
|
|
2024
Q1 | $1.65M | Buy |
99,366
+1,036
| +1% | +$17.2K | ﹤0.01% | 4009 |
|
|
2023
Q4 | $1.57M | Buy |
98,330
+36,448
| +59% | +$583K | ﹤0.01% | 4048 |
|
|
2023
Q3 | $4.71M | Buy |
61,882
+16,189
| +35% | +$1.23M | ﹤0.01% | 3619 |
|
|
2023
Q2 | $3M | Buy |
45,693
+43,329
| +1,833% | +$2.84M | ﹤0.01% | 3810 |
|
|
2023
Q1 | $141K | Sell |
2,364
-66
| -3% | -$3.95K | ﹤0.01% | 4798 |
|
|
2022
Q4 | $56.6K | Buy |
2,430
+50
| +2% | +$1.17K | ﹤0.01% | 5108 |
|
|
2022
Q3 | $80K | Buy |
2,380
+79
| +3% | +$2.66K | ﹤0.01% | 5152 |
|
|
2022
Q2 | $61K | Sell |
2,301
-29,402
| -93% | -$779K | ﹤0.01% | 5283 |
|
|
2022
Q1 | $932K | Buy |
31,703
+15
| +0% | +$441 | ﹤0.01% | 4604 |
|
|
2021
Q4 | $2.71M | Buy |
31,688
+2,260
| +8% | +$193K | ﹤0.01% | 4208 |
|
|
2021
Q3 | $2.19M | Buy |
29,428
+446
| +2% | +$33.2K | ﹤0.01% | 4224 |
|
|
2021
Q2 | $2.7M | Buy |
+28,982
| New | +$2.7M | ﹤0.01% | 4071 |
|